HemoShear Therapeutics, Inc. has raised $40 million in funding that will enable the company to complete a phase 2 study of its lead compound.
Kevin Combs is now a vital part of the rise of CVille, the life science cluster within the BHCR that is blossoming in and around the University of Virginia (UVA).
MicroGEM Acquires Jump Start, Expands Manufacturing To Accelerate Production Of Portable COVID-19 Saliva Test
Company establishes new facilities in Utah and New Hampshire to produce “Spitfire” platform for high-quality performance at the point-of-need.
CAV Angels Achieves Record Growth in Startup Investments, Expands Leadership to Further Education and Support UVA Entrepreneurial Ecosystem
Five new board appointments will support alumni outreach and deal pipeline.
Two University of Virginia researchers have been named fellows by the National Academy of Inventors in honor of their pioneering and prolific work.
Slate Bio, Inc., a pre-clinical biotechnology company developing paradigm shifting IL-2 compounds based on research conducted at the University of Virginia School of Medicine, announced today the closing of a $1.75 million venture financing.
The company’s software uses machine learning and computer vision to create a predictive algorithm, reducing the error range for diagnosis.
This effort leverages CvilleBioHub’s regional ecosystem building experience, funded in part by GO Virginia, to inform the further development of four additional BioHubs.
ZielBio Appoints Dieter Weinand Executive Chair as Company Heads Toward the Clinic with Lead Oncology Therapeutic
ZielBio appoints biotech industry veteran Dieter Weinand Executive Chair as company heads toward the clinic with lead oncology therapeutic.
Indoor Biotechnologies Featured in Nature Magazine for Gene Therapy Efforts to Develop Hypoallergenic Cats
Indoor Biotechnologies is in the early stages of developing a gene therapy against the two genes that encode the subunits of Fel d 1. Eliminating them from the salivary and...